Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

640 results about "Immunopotency" patented technology

Lactobacillus paracasei, probiotic preparation beneficial for improving immunity and preparation method of probiotic preparation

The invention provides a Lactobacillus paracasei, which has a preservation number of CGMCC (China General Microbiological Culture Collection Center) No.32951. The Lactobacillus paracasei has a preservation number of CGMCC No.32951. The Lactobacillus paracasei has a preservation number of CGMCC No.32951. The lactobacillus paracasei ID001 provided by the invention has an inhibition effect on enteropathogenic bacteria such as salmonella, escherichia coli, staphylococcus aureus and the like. The probiotic preparation is obtained through fermentation and the dendrobium officinale extract, and the probiotic preparation has the immunoregulation effect through performance verification and screening.
Owner:HUNAN NUTRITION TREE BIOTECHNOLOGY CO LTD

Compound bacterial powder preparation, and preparation method therefor and use thereof

PCT designated stage expiredWO2024260441A1Powder deliveryDispersion deliveryBiotechnologyImmunopotency
A compound bacterial powder preparation, and a preparation method therefor and the use thereof. The compound bacterial powder preparation comprises Bifidobacterium animalis, Lactiplantibacillus plantarum and Bacillus coagulans, wherein the deposit number of the Bifidobacterium animalis strain is CGMCC No.25681. The compound bacterial powder preparation can stimulate macrophage RAW264.7 of a mouse to generate cell factors TNF-α and IL-6, thereby enhancing immunity; can significantly enhance the cellular immune function, the humoral immune function and the mononuclear-macrophage function of a mouse, and has the function of enhancing immunity; and can increase the ink propelling rate and has the functional potential of relaxing the bowels.
Owner:COREE CO LTD

Difunctional cavings oligopeptide GK-8 for preventing and treating metabolic syndrome and improving immunity

The invention discloses a bifunctional cavings oligopeptide GK-8 for preventing and treating metabolic syndrome and improving immunity and application of the bifunctional cavings oligopeptide GK-8. The amino acid sequence of the cavings oligopeptide is Gly-Leu-Ser-Phe-Asp-Phe-Tyr-Lys (GLSFDFYK, called GK-8 for short). Experiments find that the GK-8 has the effects of preventing and treating the metabolic syndrome of the mice, specifically, the GK-8 can obviously reduce the body weight of the mice, improve fatty degeneration and obviously reduce insulin resistance of the mice; the levels of triglyceride TG, total cholesterol TC and low-density lipoprotein LDL-C in mouse serum are obviously reduced, and the level of high-density lipoprotein HDL-C is increased; meanwhile, it is found that the GK-8 significantly activates the immunoregulation ability of an immunosuppressive mouse induced by cyclophosphamide, for example, the weight, thymus index and spleen index of the immunosuppressive mouse are recovered; the multiplication capacity of T lymphocytes and B lymphocytes of the spleen of the mouse, the killing activity of NK cells and the like are enhanced. The bran oligopeptide GK-8 is expected to be further researched and developed into related medicine products for preventing and treating the metabolic syndrome and improving the immunity, and the bran oligopeptide GK-8 has a wide application prospect.
Owner:SHANXI UNIV

Molecular marker related to immune traits of male semi-fine wool sheep as well as detection primer and application of molecular marker

The invention provides a molecular marker related to immune traits of elephant male semi-fine wool sheep and a detection primer and application thereof, and belongs to the technical field of molecular assisted breeding. The nucleotide sequence of the molecular marker is shown as SEQ ID NO.1; the molecular marker comprises an SNP site, the SNP site is located at the 117th site of the molecular marker, the mutation basic group of the SNP site is A or G, and the immune globulin content of an individual male semi-fine wool sheep with the genotype of AG or GG at the SNP site is remarkably higher than that of an individual with the genotype of AA. The content of immune globulins IgA, IgG and IgM of an individual elephant male semi-fine-wool sheep can be judged according to the genotype of the molecular marker, the immune traits of the elephant male semi-fine-wool sheep can be rapidly and accurately evaluated, the high-immunity elephant male semi-fine-wool sheep can be screened, the molecular marker has important significance on early-stage auxiliary breeding of the elephant male semi-fine-wool sheep, the breeding period is remarkably shortened, and the breeding cost is reduced. The breeding efficiency is improved.
Owner:INST OF ANIMAL SCI & VETERINARY TIBET ACADEMY OF AGRI & ANIMAL HUSBANDRY SCI

Cattle spleen active polypeptide capable of enhancing immunity and preparation method and functional product thereof

The invention relates to the technical field of deep processing of cattle spleen, in particular to cattle spleen active polypeptide capable of enhancing immunity and a preparation method and a functional product thereof. The preparation method comprises the following steps: mincing cattle spleen, adding water, uniformly mixing, heating and curing; adding bacillus licheniformis alkaline protease to carry out hydrolysis for the first time; adding papain and bacillus subtilis flavourzyme into the first hydrolysate to carry out hydrolysis for the second time; and performing enzyme deactivation on the second hydrolysate, and sequentially performing fishy smell removal, decolorization, filtration, concentration and drying treatment to obtain the cattle spleen polypeptide. The cattle spleen polypeptide prepared by the invention can obviously enhance the immune response of a body and play a role in enhancing immunity, can be applied to a functional product for enhancing immunity as a functional factor, has the advantages of low equipment requirement, simple process, easiness in operation, high extraction efficiency and the like, is suitable for industrial production, and has a wide application prospect. The scheme of the invention has good application and economic prospects.
Owner:XIAMEN YUANZHIDAO BIOTECHNOLOGY CO LTD

Probiotic agent for enhancing immunity and improving intestinal flora and application thereof

According to the probiotic agent for enhancing the immunity and improving the intestinal flora and the application of the probiotic agent, five specific different types of bifidobacterium strains are compounded, potential interaction exists among the five strains, and the five strains can cooperate with one another, so that the effect of enhancing the immunity and improving the intestinal flora is achieved. The bifidobacteria has the advantages that the bifidobacteria has synergistic interaction in the aspects of promoting the growth of immune organs and increasing the total quantity and diversity of intestinal flora, the bifidobacteria is matched with basic fermentation strains for yogurt fermentation, meanwhile, the composite prebiotics are added for synergistic yogurt fermentation, the quantity of the bifidobacteria at the end of a shelf life after the yogurt fermentation is finished is still not less than 1 * 10 < 8 > CFU / mL or 1 * 10 < 8 > CFU / g, and the content of the bifidobacteria is not less than the stability of lactic acid bacteria in the yoghourt is remarkably improved, so that the number of viable bacteria which enter the intestinal tract of a human body and play roles is remarkably increased, and the yoghourt has relatively good tolerance in the intestinal tract; the prepared yoghurt is fine and smooth in texture, rich in taste and rich in fragrance; in addition, the immune decline and intestinal flora disorder caused by cyclophosphamide (CTX) can be remarkably improved, and a positive effect on immunological enhancement is achieved.
Owner:JIANGSU WECARE BIOTECHNOLOGY CO LTD

Application of STRN gene in improving immunity of Tibetan sheep

The invention relates to the technical field of molecular markers, in particular to application of an STRN gene in improving the immunity of Tibetan sheep. According to the STRN gene molecular marker related to the immune traits of the Tibetan sheep, the molecular marker is located at the 86920236th basic group on the No.3 chromosome of the international sheep genome Oarv4.0 version, and the mutant basic group is A or C. By detecting the basic group of the 86920236th nucleotide site on the No.3 chromosome of the Tibetan sheep, the content of immune globulins IgA and IgG of a Tibetan sheep individual can be judged, and a new SNP molecular marker resource is provided for non-diagnostic Tibetan sheep immune trait marker-assisted selection.
Owner:LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS

Breeding method for improving immunity of fishes

The invention provides a culture method for improving immunity of fishes. The culture method comprises the following steps: S1, selection of culture points; S2, specification and layout of net cages; S3, selection and throwing of fish fries; according to the fry disinfection method disclosed by the invention, the fry are soaked and disinfected by using a compound disinfectant prepared from povidone iodine, polysorbate, citric acid and vitamin C in a specific proportion, so that pathogenic microorganisms on the surfaces and gill parts of fish bodies are effectively killed. According to the breeding management, the immunity of the fish body is comprehensively enhanced by feeding the fish with an immune conditioner composed of campesterol palmitate, immunomodulatory peptide, beta-glucan and astaxanthin in a specific proportion. According to the bottom mud management, the content of harmful substances is reduced by putting a bottom mud modifier composed of sodium molybdate, nitrifying bacteria, photosynthetic bacteria, tetrandrine and sodium alginate in a specific proportion, growth of pathogenic bacteria is inhibited, nutrient substance circulation is promoted, the water quality environment is optimized, and healthy growth of fry is promoted.
Owner:SANYA SHUANGFANSHI FISHERY TECH CO LTD

Inhibition of immune cells by immune checkpoint conjugates

The present invention provides cells (Immune Checkpoint Junction 'ICE' cells) having enhanced Immune Checkpoint Junction function. In some embodiments, the ICE cells have a PD-1 conjugation function (PD-1 conjugant cells). The ICE cells reduce adaptability and innate immunity when transplanted into a subject as compared to parental cells with corresponding unmodified immune checkpoint conjugation function. In some embodiments, the PD-1 zygote cells are low immune pluripotent (HIP) cells. In further embodiments, the HIP cell is type O blood (HIPO), rhesus monkey factor (Rh) negative (HIP-), or both type O and type Rh (HIPO-). In other embodiments, the PD-1 zygote cells have been derived or differentiated from HIP, HIP-, or HIPO-cells. In other embodiments, the ICE cell expresses a ligand that binds to a suppressive immune cell receptor selected from the group consisting of a LILRB1 zygote, a LILRB3 zygote, and a TIM3 zygote. In other embodiments, the ICE cell is a PD-1 zygote cell that also expresses a ligand that binds to another inhibitory immune cell receptor selected from the group consisting of CD47, truncated CD47, a LILRB1 zygote, a LILRB3 zygote, and a TIM3 zygote.
Owner:RGT UNIV OF CALIFORNIA

SNP molecular marker related to immune traits of yak and application of SNP molecular marker

The invention relates to the technical field of molecular biological detection, in particular to an SNP molecular marker related to immune traits of yaks and application of the SNP molecular marker. According to the invention, the SNP molecular marker related to the immune traits of yaks is obtained through screening and is located at the 55577127th position on the 22 # chromosome of a yak reference genome LUBosgruv3.0 version, and a mutant basic group is G or A. The content of immune globulin A, immune globulin G and immune globulin M of a yak individual can be obtained by utilizing the SNP molecular marker, a new SNP molecular marker resource is provided for non-diagnostic yak immune character marker-assisted selection, and a basis is provided for high-immunity yak breeding.
Owner:LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS

Molecular marker related to immune index of yak and application of molecular marker in breeding

The invention belongs to the technical field of molecular biological detection, and particularly relates to a molecular marker related to immune indexes of yaks and application of the molecular marker in breeding. The SNP molecular marker related to the immune traits of the yak is obtained through screening and is located at the 26593056th basic group of chromosome 3 of a yak reference genome LUBosgruv3.0 version, and the mutant basic group is G or A. The content of immune globulin A, immune globulin G and immune globulin M of a yak individual can be obtained by utilizing the SNP molecular marker, a new SNP molecular marker resource is provided for non-diagnostic yak immune character marker-assisted selection, and a basis is provided for high-immunity yak breeding.
Owner:LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS

Application of ackermann muciniphile or external vesicles thereof in preparation of drugs for treating schistosomiasis

The invention belongs to the technical field of biological medicines, and relates to application of Ackermann muciniphile or its external vesicles in preparation of a drug for treating schistosomiasis. The anti-infection immunity of a host is enhanced by adjusting intestinal flora balance (recovering diversity and composition) and improving immune response (adjusting macrophage, CD8 + T cell recruitment and Th1 / Th2 balance); meanwhile, the intestinal barrier function is improved, and pathogen invasion and inflammation are reduced; hepatic granuloma and hepatic fibrosis caused by schistosome infection are obviously relieved, and the liver function is improved; the key effect of the MIF gene in immunoregulation is disclosed, and a new direction is provided for schistosomiasis immunotherapy. Besides, the probiotics are high in treatment safety and free of obvious side effects, can be combined with chemotherapy to enhance the curative effect and reduce the side effects and drug resistance of chemical drugs, provides a lasting and comprehensive adjuvant therapy scheme for the schistosomiasis, and has important clinical application potential.
Owner:HUBEI UNIV OF MEDICINE

Active collagen peptide with immune regulation function as well as preparation method and application of active collagen peptide

ActiveCN120365413AConnective tissue peptidesConfectioneryImmunopotencyImmunologic Competence
The invention belongs to the technical field of active peptide preparation, and particularly relates to an active collagen peptide with an immunoregulation function and a preparation method and application thereof. The active collagen peptide with an immunoregulation function is prepared by using a method of performing composite enzymolysis and separating and collecting specified collection liquid by using a chromatographic column, and a new thought is provided for improving the immunity; the prepared active collagen peptide can significantly improve the proliferative activity, phagocytic ability and NO secretion amount of RAW264.7 cells and change the cell morphology, has an important regulation effect on immune balance recovery of immunosuppression model mice, and can regulate the problem of low immunologic function of mice induced by cyclophosphamide, regulate immune balance and improve the body immunity.
Owner:QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES) +1

Application of medicine composition in preparation of medicine for improving immunity

The invention is applicable to the technical field of biological medicines, and provides an application of a pharmaceutical composition in preparation of a medicine for improving immunity, the pharmaceutical composition comprises the following raw materials in percentage by weight: 45-6% of ginsenoside Rh, 2-4% of ginsenoside Rk3, 20-30% of ginsenoside Rg3, 3-15% of ginsenoside Rg513, 18-10% of ginsenoside Rk8, and the balance of ginseng extract, totaling 100%. The pharmaceutical composition provided by the invention can enhance the activity of immune cells, regulate the function of an immune system and realize efficient absorption and utilization so as to comprehensively improve the immunocompetence of a body, strengthen physique and help to resist disease invasion, and meanwhile, the pharmaceutical composition as a traditional Chinese medicine has extremely high stability and no toxic or side effect, and is suitable for people at all stages.
Owner:YANBIAN ANDIKANGHUA BIOTECHNOLOGY CO LTD

Methods and compositions for using plasma cell depleting agents and / or b cell depleting agents to suppress host Anti-AAV antibody response and enable AAV transduction and re-dosing

Provided herein are methods of inserting a nucleic acid encoding a polypeptide of interest into a target genomic locus in a cell or a population of cells in a subject, methods of expressing a polypeptide of interest from a target genomic locus in a cell or a population of cells in a subject, methods of treating an enzyme deficiency in a subject in need thereof, and methods of preventing or reducing the onset of a sign or symptom of an enzyme deficiency in a subject in need thereof. Some methods, such as when a subject has preexisting against an immunogen to be administered, use plasma cell depleting agents or combinations comprising plasma cell depleting agents to mitigate immune response and facilitate redosing of nucleic acid constructs encoding a polypeptide of interest and nuclease agents targeting a target genomic locus to achieve, for example, a step-wise increase in expression of a polypeptide of interest in a subject following insertion of the nucleic acid construct without overshooting. Other methods, such as when a subject has no preexisting immunity against an immunogen to be administered, use B cell depleting agents (e.g., anti-CD20xCD3 antibody or functional fragment thereof) to mitigate immune response and facilitate redosing of nucleic acid constructs encoding a polypeptide of interest and nuclease agents targeting a target genomic locus to achieve, for example, a step-wise increase in expression of a polypeptide of interest in a subject following insertion of the nucleic acid construct without overshooting.
Owner:REGENERON PHARMACEUTICALS INC

Porcine D-type coronavirus S protein and recombinant adenovirus

The invention discloses a porcine D-type coronavirus S protein and a recombinant adenovirus, and the porcine D-type coronavirus S protein expressed by a live vector vaccine has the following characteristics: on the basis of a PDCoV SC strain S protein sequence, an MDAMKRGLCCVLLLCGAVFVSN TPA secretion signal peptide sequence is inserted into an N segment, a GSGYIPEAPRDGQAYVRKDGEWVLLSTFGSGHHHHHH tag is inserted into a C end, and after S1 and S2 cleavage sites are mutated into GGSGGGGSGGGS, sequence optimization is carried out according to the characteristics of a Sus Scrofa codon. The vaccine constructed by the invention can effectively induce immune animals to generate specific immunity, and is applied to clinical application to provide a scientific technical means for prevention and control of PDCoV.
Owner:SICHUAN HUASHEN ANIMAL BIOLOGICAL PRODS

Albumin peptide for promoting growth and development as well as preparation method and application thereof

The invention provides an albumin peptide for promoting growth and development as well as a preparation method and application thereof, and belongs to the technical field of food science. According to the albumin peptide provided by the invention, denatured egg white is taken as a substrate, firstly, chymotrypsin is used for prehydrolysis, after prehydrolysis is completed, the temperature and pH are adjusted, and then alkaline protease and chymotrypsin are added for synergistic hydrolysis. The prepared albumin peptide is small in molecular weight and easy to digest and absorb, and has the effects of promoting growth and development, improving macrophage proliferation capacity, improving immunity and the like.
Owner:BEIJING HONGJIU LIFE SCIENCES RESEARCH INSTITUTE CO LTD

SNP (Single Nucleotide Polymorphism) molecular marker related to immune traits of yaks, detection method and application of SNP molecular marker

The invention relates to the technical field of molecular biological detection, in particular to an SNP (Single Nucleotide Polymorphism) molecular marker related to immune traits of yaks and application of the SNP molecular marker. According to the invention, the SNP molecular marker related to the immune traits of yaks is obtained through screening and is located at the 163684421th site on a chromosome 1 of a yak reference genome LUBosgruv3.0 version, and a mutant basic group is C or T. The content of immune globulin A, immune globulin G and immune globulin M of a yak individual can be obtained by utilizing the SNP molecular marker, a new SNP molecular marker resource is provided for non-diagnostic yak immune character marker-assisted selection, and a basis is provided for high-immunity yak breeding.
Owner:LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS

Spina date seed peptide zinc chelate as well as preparation method and application thereof

The invention belongs to the technical field of food processing, and provides a spina date seed peptide zinc chelate as well as a preparation method and application thereof. The spina date seed peptide zinc chelate is stable in performance and high in absorption efficiency. The preparation method comprises the following steps: degreasing a spina date seed medicinal material; preparing spina date seed protein; preparing spina date seed polypeptide; carrying out chelation reaction on the spina date seed polypeptide and zinc sulfate heptahydrate; and separating a chelation reaction product. The spina date seed peptide zinc chelate prepared by the invention can be directly used as a natural immunopotentiator to improve the immunity of a human body. The method has the advantages of short production cycle, low cost, no pollution to the environment, abundant nutrition, high protein content, small particle size, high safety and high utilization rate of effective components, and can be widely applied to the fields of foods, medicines and health care.
Owner:SHANXI UNIV OF CHINESE MEDICINE

Bacterial strain with effects of resisting allergy and improving immunity and application of bacterial strain

The invention belongs to the technical field of preparation of probiotics, and provides a bacterial strain with anti-allergic and immunity-improving effects and application of the bacterial strain. According to the method, a three-layer physical self-assembly structure is adopted, and polysaccharide-polyphenol layer-by-layer self-assembly coating treatment, lipid insertion layer treatment and calcium ion crosslinking protection coating treatment are sequentially carried out. And mannan oligosaccharide MOS and / or galactooligosaccharide GOS are / is mixed in the chitosan layer in a ratio of 0.05-0.15% w / v, and the surface sugar ligand density reaches 4-8 [mu] g per 10 CFU. The coating is constructed under the condition that the pH value is 5.4-5.8; the thickness of the lipid layer is 20-80 nm when the pH value is 5.6-6.2; the cross-linked layer is treated at the pH of 6.0-6.5, so that the gastric acid environment is stable for 2 hours, and the gastric acid is controllably released in intestinal juice for 2-4 hours. The prepared strain has the total thickness of 220-900 nm, the outermost layer coverage rate is larger than or equal to 85%, the gastric juice survival rate is remarkably improved, the strain can be prepared into an oral preparation to be used for preventing and relieving allergic diseases, the viable count of each dose is 1 * 10 <-1 > * 10 <-1 > CFU, and the process is mild and suitable for industrial production.
Owner:SHANGHAI HELPLIFES TECH CO LTD

Method for preparing lactoferrin active peptide through double enzymolysis and application of lactoferrin active peptide

The invention discloses a method for preparing lactoferrin active peptide through double-enzymolysis and application of the lactoferrin active peptide. The method comprises the following steps: preparing lactoferrin into a lactoferrin aqueous solution; adding pepsase into the lactoferrin aqueous solution to perform enzymolysis, and performing enzyme deactivation after enzymolysis to obtain a primary lactoferrin enzymolysis product; adding trypsin into the primary enzymolysis product of lactoferrin for enzymolysis, and performing enzyme deactivation after enzymolysis to obtain a secondary enzymolysis product of lactoferrin; and centrifuging the lactoferrin secondary enzymolysis product at 4 DEG C, taking supernate, and freeze-drying to obtain the lactoferrin active peptide. Animal experiments prove that the lactoferrin active peptide prepared by the invention has a good effect of enhancing immunity, and can be applied to preparation of products capable of improving immunocompetence, such as novel infant formula milk powder.
Owner:FUZHOU UNIV +2

Method for amplifying NK (Natural Killer) cells by taking NK92 cells as trophoblast cells

PendingCN119391637AIncrease multiplehigh activityNucleic acid vectorAntiviralsPeripheral blood mononuclear cellActivated Natural Killer Cell
The invention belongs to the field of immunology, and particularly relates to amplification of NK cells, in particular to a method for amplifying NK cells by using NK92 cells as trophoblast cells, which specifically uses NK92 cells secreting IL-21, IL-15 and IL-18 as trophoblast cells and PBMC as seed cells to directionally amplify and activate natural killer cells, and comprises the following steps: transfecting an NK92 cell strain through lentivirus; the NK92 cell strain capable of stably expressing IL-21, IL-15 and IL-18 is obtained; then obtaining monoclonal cells of NK92 cells through flow sorting and limit dilution methods, finally culturing and amplifying, preparing NK92 trophoblasts through irradiation, and mixing the NK92 trophoblasts with PBMC (peripheral blood mononuclear cells) for culturing so as to prepare the NK cells. According to the method, the NK cells can be efficiently amplified and activated, and the activated NK cells can improve the immunity of the organism, so that tumor and virus infection is resisted. The invention has wide application in medicine.
Owner:JIANGSU TOPCEL-KH PHARMACEUTICAL CO LTD

Polypeptide and application thereof in enhancing immunity and / or resisting inflammation

The invention relates to the technical field of biology, and particularly discloses a polypeptide and application thereof in enhancing immunity and / or resisting inflammation. The invention provides a polypeptide. The amino acid sequence of the polypeptide is shown as SEQ ID NO. 1. The compound has the dual functions of regulating immunity and resisting inflammation, on one hand, the immune function of cells under the normal condition can be enhanced, and on the other hand, cell inflammation can be relieved by reducing the phosphorylation level of key protein in an LTR4-NF-kappa B signal channel in the inflammatory state. The polypeptide is low in cytotoxicity, high in safety, simple in preparation method and low in cost, can be used as an ideal immune and anti-inflammatory regulator, and has good application potential and value.
Owner:CHINA AGRI UNIV

Probiotic composition capable of improving immunity and application of probiotic composition in treatment of skin allergy

The invention provides a probiotic composition as well as a preparation method and application thereof. The composition is prepared from lactobacillus rhamnosus GG, lactobacillus acidophilus NCFM, an anti-IL-4R alpha monoclonal antibody, an inulin-beta-glucan compound and sodium alginate-chitosan microspheres. The composition regulates immune balance through a specific probiotic strain, blocks an IL-4 / IL-13 signal channel in combination with an anti-IL-4R alpha monoclonal antibody, and improves viable bacterium stability and bioavailability through a microsphere delivery technology. The probiotic composition shows a remarkable anti-allergic effect in an atopic dermatitis mouse model, and can reduce the serum IgE level, reduce the skin inflammatory response and reduce the STAT6 phosphorylation level. The probiotic composition disclosed by the invention has a wide application prospect in the aspect of treating atopic dermatitis and other immune-related diseases.
Owner:GUANGDONG RUIDAN BIOTECHNOLOGY DEVELOPMENT CO LTD

Costrum peptide composition and application thereof

The invention mainly provides a novel colostrum peptide composition (composite peptide composition) and application thereof, the colostrum peptide composition takes colostrum hydrolyzed peptide, collagen peptide and casein peptide as necessary components, the three components have synergistic effect to achieve the effects of assisting in resisting fatigue, assisting in resisting oxidation (delaying senescence) and improving immunity, and in addition, the colostrum peptide composition has the effects of resisting fatigue and resisting oxidation (delaying senescence) and improving immunity. The synergistic effect can be embodied in the form of synergistic reduction and synergism.
Owner:HEILONGJIANG FEIHE DAIRY CO LTD

Treatment of COVID-19 and methods thereof

The present invention relates to treatment of COVID-19 and methods thereof. A vaccine composition for inducing immunity against coronavirus in a subject comprises a recombinant nucleic acid encoding an N-ETSD, which is a modified nucleocapsid protein comprising an endosomal targeting sequence, and / or a recombinant nucleic acid encoding an S-fusion, which is a modified spike protein with improved surface expression. The vaccines can be formulated as recombinant nucleic acids, recombinant yeasts, and / or recombinant viruses, such as adenoviruses, and can be administered via injection and / or mucosal delivery.
Owner:NANTCELL INC

Construction method and application of African swine fever virus strain

The invention relates to the technical field of viruses, in particular to a construction method and application of an African swine fever virus strain. According to the invention, the three virulence genes MGF110-9L, EP402R and I73R of the African swine fever virus are taken as targets for the first time to construct a virus strain with deletion of the three virulence genes, and the virus strain is found to be capable of effectively reducing the virus toxicity but retaining better immunogenicity, can improve the immunity of an organism to the African swine fever virus, and has a relatively great application prospect.
Owner:GUANGDONG MINGZHU BIOTECHNOLOGY CO LTD

Lactoferrin composition and application thereof for improving immunity by regulating macrophage immune activity

The present invention discloses a lactoferrin composition and its application for improving immunity by regulating macrophage immune activity, and belongs to the technical field of functional compositions. The present invention obtains a lactoferrin composition with regulating macrophage immune activity by compounding lactoferrin, α-lactalbumin, N-acetylneuraminic acid and yeast β-glucan in a specific ratio, the raw material of the composition is easy to obtain, and four components work together to significantly enhance its phagocytic activity without changing the activity of macrophages, regulate the polarization state of macrophages in inflammatory response, inhibit macrophages from polarizing to pro-inflammatory M1 type, and promote macrophages to polarize to anti-inflammatory M2 type; At the same time, the composition can also enhance the antigen presentation ability of macrophages and the activation of immune T cells, and improve body immunity. Therefore, the composition provided by the present invention can be used to prepare health products, food or medicines, etc. that improve immunity.
Owner:HANGZHOU QIANDAOHU KANGNUOBANG HEALTH PROD CO LTD